Rapid growth in emerging economies and technological development in the urinalysis diagnostics sphere with the advent of portable and battery-operated urinalysis devices are key factors contributing to high CAGR of the market during the forecast period.
Market Size – USD 3.12 Billion in 2019
Market Growth – CAGR of 7.5
arket Trends – Product launches and research for advanced Urinalysis
The Urinalysis Market’s valuation was USD 3.12 Billion in the year 2019 and has been projected to reach USD 5.64 Billion by 2027, at 7.5% CAGR through the forecast period. Providing valuable patient’s health information to physicians and doctors, urinalysis has become crucial for screening foreign substances in urine. It aids in the analysis of liver and urological disease, renal indications, UTI (urinary tract infection), diabetes mellitus, and general hydration. Urinalysis mainly detects the presence of blood, leucocytes, glucose, and nitrite in urine. Further analysis of blood and/or urine is required, depending on the presence of such substances. Urinalysis should not be used as a guiding treatment in isolation due to the chances of false positives, regardless of its effectivity as a screening tool. For instance, glucose and nitrite can occur within the sample if left for too long or contaminated. Apart from detecting these substances, urinalysis can also be used for detecting infections and systemic diseases. For testing urine, reagent strips are an easy and convenient method, providing crucial information regarding patient’s condition.
Rapid advances in technology pave the way for automated urinalysis’s stellar progress. By using reflectometry, urinary test strips’ quantitative reading has become easier. On the other hand, incorporation of cutting-edge technology like CMOS (complementary metal oxide semiconductor) has shown promise in the testing of microalbuminuria, enhancing analytical sensitivity. Analysis of urine particle which is microscopy-based has progressed steadily over the years, enabling clinical laboratories’ throughput. As an alternative to automated microscopy, urinary flow cytometric data analysis has helped in the differentiation of distinct urinary microorganisms. Automated urinalysis aids in the monitoring and diagnosis of a broad array of urological and nephrological conditions and screening of urinary tract. Latest applications of automated urinalysis show fruitful outcomes in the fast identification of urothelial cancer. Concomitantly, for early detection of the urinary pathogens, the introduction of MALDI-TOF MS has provided positive outcomes. Automated urinalysis has showcased a remarkable technical progress in the last two decades. Instruments based on flow cytometry and microscopy generate effective and clinically useful results, whereas the reading of automated test strip provides further value.
Increasing cases of kidney diseases, rising geriatric population, and PPACA implementation are major factors accelerating market growth. Rapid technological advancements and integrated systems as well as urinalysis through smartphones grant several avenues in the market, thus, fueling industry’s growth. High occurrence of diabetes leads to the increasing sales of different urinalysis devices, disposable, dipsticks worldwide. However, the U.S. government’s tax implementation on a few devices, restricted healthcare infrastructure in poor countries, and stringent regulations in procedures are obstructing the growth of the market.
To identify key trends in the industry, click on the link below:
Further key findings from the report suggest
- Automated analyzers of urine sediment and automated readers of urine strip, including Elektronika Kft, UriSed 2 from 77, and UriSed mini respectively represent modern instruments, which are technologically modified, are accessible in the market.
- Increasing clinical needs of considerable population coupled with rising target population, especially in the regions which are under-developed provides lucrative avenues for significant industry’s growth.
- DIRUI Industrial Co. Ltd., a renowned market player, inaugurated the FUS 1000 Automated Urine Analyzer, in the year 2018.
- A few extensively used urinalysis instruments include the analyzers of urine sediment, biochemical urine which are automated and semi-automated, and microscopic urine.
- Rising cases of kidney diseases, diabetes, and UTI, and the rapid introduction of modern, user-friendly, and non-invasive urinalysis tools would further promote the market’s growth.
- North America is leading the industry, registering 30.7% of share in the year 2018. The country, U.S. has contributed the highest share of market revenue in the overall regional market.
- The segment of sediment urinalysis has been projected to showcase stellar CAGR rate over the estimated duration.
- Renowned market players are Danaher Corporation, Hoffmann-LA Roche AG, United Medical Electronic Group Co., Ltd. Mindray Medical International Limited, Siemens AG, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray, Inc. and Acon Laboratories, Inc.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2229
For this report, Reports and Data has segmented the Urinalysis Market based on product, test type, application, and region:
Product Outlook (Revenue, USD Million; 2017–2027)
Test Type Outlook (Revenue, USD Million; 2017–2027)
- Biochemical urinalysis
- Sediment urinalysis,
- Pregnancy & fertility tests
Application Outlook (Revenue, USD Million; 2017–2027)
- Kidney Disease
End-User Outlook (Revenue, USD Million; 2017–2027)
- Hospitals & clinics
- Diagnostic laboratories
- Home care settings
- Research laboratories & institutes
Regional Outlook (Revenue in USD Million; 2017–2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Early Diners Are Offered Free Customization
Get Attractive Discount on “Urinalysis Market – Forecast to 2027” @ https://www.reportsanddata.com/discount-enquiry-form/2229
Table of Contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Rising prevalence of kidney disease
3.2. Increase in geriatric population
3.3. Rapid growth in emerging economies and technological development
3.4. Awareness about urinalysis tests
Chapter 4. Urinalysis Market Segmentation & Impact Analysis
4.1. Urinalysis Segmentation Analysis
4.2. Urinalysis Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Urinalysis Market Impact Analysis
4.4.1. Market driver analysis
184.108.40.206. High prevalence of target diseases across the world
220.127.116.11. Increasing demand for pregnancy tests
4.4.2. Market restraint analysis
18.104.22.168. Lack of awareness regarding tests
22.214.171.124. High Cost
4.5. Key opportunities prioritized
4.6. Urinalysis Pricing Analysis
4.7. Industry analysis – Porter’s
4.8. Urinalysis PESTEL Analysis
Ask for your specific company profile and country level customization on reports.
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release About Urinalysis Market @ https://www.reportsanddata.com/press-release/global-urinalysis-market